ArticleHead & neck2026
Prognostic Significance of Solid Subtype of Papillary Thyroid Carcinoma: Analysis of 63 Patients.
Article in Head & neck, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic Significance of Solid Subtype of Papillary Thyroid Carcinoma: Analysis of 63 Patients.Head & neck · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSolid subtype of papillary thyroid carcinoma (SSPTC) is an uncommon subtype of papillary thyroid cancer (PTC) and its prognostic significance is still controversial. The aim of this review is to present the clinicopathological features of SSPTC and compare its clinical behavior with classical PTC (cPTC).
methodsWe retrospectively analyzed patients who underwent thyroidectomy for SSPTC and compared the clinicopathological findings and clinical outcomes with those of patients with cPTC.
resultsAmong 4937 patients treated for PTC, 63 (1.3%) were diagnosed with SSPTC, of which 76.2% were female, with a median age of 40 years, 3.2% had prior cervical irradiation, and the median diameter of the tumor was 15 mm. Compared to cPTCs, SSPTCs were larger (median tumor diameter: 15 vs. 9 mm), more symptomatic (non-incidentally discovered) and were associated with an elevated risk for multifocality, extrathyroidal extension, lympho-vascular invasion, lymph node metastasis, extra-nodal extension, and distant metastasis. After a mean follow-up of 58.5 months, rates of biochemical incomplete response to treatment and structural recurrence were higher when compared to those of cPTC. None of the patients who demonstrated an excellent response to treatment presented cancer recurrence during follow-up. Distant metastasis occurred in 3 patients (4.8%). There were no cancer-related deaths.
conclusionsSSPTC is an aggressive histological subtype of PTC associated with adverse prognostic features, including larger tumor size, multifocality, and extrathyroidal extension, which correlate with a higher risk of cancer recurrence and therefore should be considered for accurate risk stratification, comprehensive management, and close follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.